Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers.


Journal

Cell cycle (Georgetown, Tex.)
ISSN: 1551-4005
Titre abrégé: Cell Cycle
Pays: United States
ID NLM: 101137841

Informations de publication

Date de publication:
10 2023
Historique:
pmc-release: 15 12 2024
medline: 17 12 2023
pubmed: 27 11 2023
entrez: 27 11 2023
Statut: ppublish

Résumé

Colorectal cancer (CRC) and gastric cancer (GC), are the two most common cancers of the gastrointestinal tract, and are serious health concerns worldwide. The discovery of more effective biomarkers for early diagnosis, and improved patient prognosis is important. Non-coding RNAs (ncRNAs), including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), can regulate cellular processes such as apoptosis and the epithelial-mesenchymal transition (EMT) leading to progression and resistance of GC and CRC tumors. Moreover these pathways (apoptosis and EMT) may serve as therapeutic targets, to prevent metastasis, and to overcome drug resistance. A subgroup of ncRNAs is common to both GC and CRC tumors, suggesting that they might be used as biomarkers or therapeutic targets. In this review, we highlight some ncRNAs that can regulate EMT and apoptosis as two opposite mechanisms in cancer progression and metastasis in GC and CRC. A better understanding of the biological role of ncRNAs could open up new avenues for the development of personalized treatment plans for GC and CRC patients.

Identifiants

pubmed: 38009668
doi: 10.1080/15384101.2023.2286804
pmc: PMC10730205
doi:

Substances chimiques

RNA, Untranslated 0
MicroRNAs 0
RNA, Long Noncoding 0
Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2302-2323

Références

Onco Targets Ther. 2020 Jul 31;13:7571-7583
pubmed: 32801774
Cancer Sci. 2018 Apr;109(4):1044-1054
pubmed: 29450946
Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3771-3778
pubmed: 29949152
Carcinogenesis. 2014 Jan;35(1):173-83
pubmed: 23929433
Am J Transl Res. 2019 Sep 15;11(9):5338-5356
pubmed: 31632515
Cancer Sci. 2019 Feb;110(2):662-673
pubmed: 30485589
IUBMB Life. 2015 Mar;67(3):191-201
pubmed: 25873402
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):9957-9964
pubmed: 33090400
Oncol Lett. 2018 Mar;15(3):3197-3201
pubmed: 29435057
Acta Biochim Biophys Sin (Shanghai). 2019 Jul 10;51(7):661-668
pubmed: 31281935
Cell Physiol Biochem. 2016;39(2):453-66
pubmed: 27383203
Int J Clin Exp Pathol. 2015 Nov 01;8(11):14131-40
pubmed: 26823726
J Cell Biochem. 2020 Jan;121(1):332-343
pubmed: 31222825
J Cell Physiol. 2019 Jul;234(7):10926-10933
pubmed: 30569489
J Exp Clin Cancer Res. 2014 Apr 24;33:34
pubmed: 24758269
Clin Chim Acta. 2020 Feb;501:252-257
pubmed: 31730812
Med Oncol. 2014 Nov;31(11):253
pubmed: 25326054
Pathol Oncol Res. 2017 Jul;23(3):651-656
pubmed: 28013491
Dig Dis Sci. 2014 Jan;59(1):98-107
pubmed: 24026406
Tumour Biol. 2017 Apr;39(4):1010428317698354
pubmed: 28443467
J Cell Mol Med. 2020 Dec;24(24):14502-14513
pubmed: 33169519
Cancer Cell Int. 2019 Dec 27;19:354
pubmed: 31889906
Int J Biol Sci. 2011 May 05;7(5):567-74
pubmed: 21552422
Onco Targets Ther. 2020 Nov 25;13:12181-12193
pubmed: 33268996
Cancer Cell Int. 2013 Jul 08;13(1):68
pubmed: 23834902
Int J Biol Macromol. 2018 Feb;107(Pt B):2620-2629
pubmed: 29080815
Braz J Med Biol Res. 2017 Feb 20;50(3):e6079
pubmed: 28225893
Oncogene. 2021 Jul;40(28):4695-4708
pubmed: 34140641
DNA Cell Biol. 2017 Feb;36(2):159-167
pubmed: 28075173
J Cell Biochem. 2020 Jan 2;:
pubmed: 31898357
Cancer Manag Res. 2019 Feb 22;11:1805-1816
pubmed: 30863186
BMC Cancer. 2019 Aug 20;19(1):821
pubmed: 31429725
Oncol Rep. 2018 Jul;40(1):319-330
pubmed: 29749537
Biofactors. 2022 Jan;48(1):164-180
pubmed: 34882869
J Cell Biochem. 2018 Mar;119(3):2787-2796
pubmed: 29053187
Cell Death Dis. 2017 Oct 5;8(10):e3059
pubmed: 28981115
Cancer Gene Ther. 2010 Jun;17(6):398-408
pubmed: 20094072
Mol Ther Nucleic Acids. 2017 Sep 15;8:356-369
pubmed: 28918035
Acta Biochim Biophys Sin (Shanghai). 2013 Nov;45(11):963-72
pubmed: 24108762
Cell Mol Biol Lett. 2019 Jul 27;24:50
pubmed: 31372165
Pathol Oncol Res. 2020 Jan;26(1):475-482
pubmed: 31642035
Carcinogenesis. 2014 Dec;35(12):2723-30
pubmed: 25239640
Eur Rev Med Pharmacol Sci. 2019 May;23(10):4185-4191
pubmed: 31173289
Cell Death Dis. 2014 Apr 24;5:e1197
pubmed: 24763054
Chin Med J (Engl). 2020 Aug 5;133(15):1856-1867
pubmed: 32649523
Cancer Sci. 2018 May;109(5):1393-1403
pubmed: 29569792
J Cancer Res Clin Oncol. 2016 Mar;142(3):581-92
pubmed: 26515696
World J Gastroenterol. 2015 Apr 21;21(15):4564-73
pubmed: 25914465
J Cell Physiol. 2018 Sep;233(9):6401-6407
pubmed: 29574722
Oncol Lett. 2017 May;13(5):3151-3158
pubmed: 28521420
Br J Cancer. 2020 Sep;123(7):1123-1130
pubmed: 32546833
Pathology. 2014 Aug;46(5):396-401
pubmed: 24977734
Oncol Rep. 2014 May;31(5):2055-62
pubmed: 24626817
Noncoding RNA Res. 2020 Jul 09;5(3):109-115
pubmed: 32695943
Semin Oncol Nurs. 2017 May;33(2):165-171
pubmed: 28343837
Cell. 2011 Nov 11;147(4):742-58
pubmed: 22078876
Int J Oncol. 2011 Jul;39(1):169-75
pubmed: 21503572
Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6486-6496
pubmed: 31378888
Cell Physiol Biochem. 2018;47(4):1432-1441
pubmed: 29940575
Cancer Cell Int. 2016 Jun 10;16:42
pubmed: 27293381
Oncol Lett. 2020 Jul;20(1):914-920
pubmed: 32566020
Chin Med J (Engl). 2014;127(12):2357-62
pubmed: 24931256
Cell Physiol Biochem. 2018;46(6):2445-2459
pubmed: 29742512
Cell Death Dis. 2016 Aug 11;7(8):e2333
pubmed: 27512954
World J Gastroenterol. 2019 Aug 7;25(29):3972-3984
pubmed: 31413531
Mol Ther Nucleic Acids. 2019 Dec 6;18:320-331
pubmed: 31614322
Oncol Res. 2018 Sep 14;26(8):1295-1305
pubmed: 29402343
J Cell Biochem. 2017 Dec;118(12):4129-4140
pubmed: 28401648
Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):1168-1176
pubmed: 32096147
Theranostics. 2018 Jun 24;8(14):3932-3948
pubmed: 30083271
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2452-2461
pubmed: 32196596
Clin Cancer Res. 2011 Dec 15;17(24):7574-83
pubmed: 21994419
Int J Mol Sci. 2022 Apr 26;23(9):
pubmed: 35563178
Mol Med Rep. 2016 Jan;13(1):572-8
pubmed: 26573417
Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):790-796
pubmed: 28276823
Am J Cancer Res. 2017 Oct 01;7(10):2070-2080
pubmed: 29119055
Cancer Lett. 2017 Dec 1;410:212-227
pubmed: 28965855
Oncogene. 2014 Jun 19;33(25):3267-76
pubmed: 23893241
BMC Cancer. 2014 May 06;14:319
pubmed: 24884417
Acta Biochim Biophys Sin (Shanghai). 2017 Feb 6;49(2):119-127
pubmed: 28069585
Oncol Rep. 2016 May;35(5):2583-91
pubmed: 26936591
Br J Cancer. 2014 Jan 21;110(2):450-8
pubmed: 24281002
Hum Cell. 2020 Oct;33(4):1133-1141
pubmed: 32918700
J Cell Sci. 2013 Jan 1;126(Pt 1):21-9
pubmed: 23516327
J Cancer. 2022 Jan 1;13(3):918-931
pubmed: 35154459
Cancer Manag Res. 2020 Jul 09;12:5587-5596
pubmed: 32753971
Adv Exp Med Biol. 2013;774:1-20
pubmed: 23377965
J BUON. 2017 May-Jun;22(3):696-703
pubmed: 28730777
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13421-6
pubmed: 18755897
Pharmazie. 2012 Jul;67(7):645-51
pubmed: 22888524
Cell Death Dis. 2013 Jun 06;4:e659
pubmed: 23744359
Sci Signal. 2017 Jun 13;10(483):
pubmed: 28611183
Mol Cancer. 2021 Jul 30;20(1):99
pubmed: 34330299
Noncoding RNA. 2018 Jan 30;4(1):
pubmed: 29657300
Clin Cancer Res. 2012 Jun 1;18(11):3054-70
pubmed: 22452939
Oncogene. 2015 Nov 5;34(45):5648-61
pubmed: 25728677
Mol Ther. 2018 Mar 7;26(3):774-783
pubmed: 29456019
J Cell Biochem. 2019 Nov;120(11):18629-18639
pubmed: 31338872
Annu Rev Cell Dev Biol. 2011;27:347-76
pubmed: 21740232
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
Oncogene. 2013 Feb 28;32(9):1183-92
pubmed: 22508480
J Cell Physiol. 2019 Aug;234(8):13747-13761
pubmed: 30656681
Onco Targets Ther. 2018 Dec 12;11:9013-9025
pubmed: 30588014
J Cancer Res Clin Oncol. 2017 Oct;143(10):1915-1927
pubmed: 28528497
Dev Dyn. 2018 Mar;247(3):405-431
pubmed: 28691356
Med Sci Monit. 2016 Oct 01;22:3506-3513
pubmed: 27694794
Mol Ther Nucleic Acids. 2021 Feb 24;24:164-174
pubmed: 33767913
Pathol Res Pract. 2019 Dec;215(12):152687
pubmed: 31640897
Mol Cancer Ther. 2018 May;17(5):1061-1069
pubmed: 29440295
Mol Cancer. 2018 Feb 27;17(1):68
pubmed: 29486794
Cancers (Basel). 2020 Mar 17;12(3):
pubmed: 32192092
Chin J Cancer. 2010 Dec;29(12):1006-11
pubmed: 21114921
Cytokine Growth Factor Rev. 2022 Apr;64:33-45
pubmed: 35219587
Int J Mol Sci. 2018 Feb 02;19(2):
pubmed: 29393886
World J Gastroenterol. 2016 Jun 14;22(22):5254-9
pubmed: 27298568
Mol Cancer. 2017 Jan 23;16(1):18
pubmed: 28114937
Cell Mol Biol (Noisy-le-grand). 2020 Apr 20;66(1):95-100
pubmed: 32359391
J Cancer. 2021 Jul 6;12(18):5394-5403
pubmed: 34405002
Clin Chim Acta. 2020 Sep;508:77-91
pubmed: 32407782
Dig Dis. 2022;40(4):436-447
pubmed: 34348271
Biomed Pharmacother. 2017 Feb;86:450-456
pubmed: 28012924
Oncol Res. 2018 Aug 23;26(7):1023-1029
pubmed: 29321084
Food Chem Toxicol. 2019 Nov;133:110779
pubmed: 31472228
Nat Rev Genet. 2016 May;17(5):272-83
pubmed: 27040487
Mol Cancer. 2017 Mar 4;16(1):53
pubmed: 28257633
Int J Clin Exp Pathol. 2019 Aug 01;12(8):2887-2897
pubmed: 31934125
Biochem Biophys Res Commun. 2014 Jun 6;448(3):315-22
pubmed: 24388988
Sci Rep. 2016 Mar 29;6:23772
pubmed: 27021515
Biochem Biophys Res Commun. 2013 May 10;434(3):688-94
pubmed: 23603256
Mol Genet Genomics. 2018 Oct;293(5):1245-1253
pubmed: 29948330
Cell Biochem Biophys. 2015 May;72(1):275-82
pubmed: 27040946
Dig Liver Dis. 2020 Mar;52(3):331-338
pubmed: 31530437
Cell Death Dis. 2018 Aug 28;9(9):854
pubmed: 30154401
Mol Cell Biochem. 2019 Apr;454(1-2):177-189
pubmed: 30357530
Biomed Pharmacother. 2015 Oct;75:129-36
pubmed: 26297542
EMBO J. 2011 Aug 23;30(18):3667-83
pubmed: 21863020
Mol Cancer. 2015 Oct 13;14:180
pubmed: 26463716
Cell Physiol Biochem. 2018;51(5):2212-2223
pubmed: 30537730
Cell Death Dis. 2017 Aug 24;8(8):e3011
pubmed: 28837144
J Exp Clin Cancer Res. 2016 Sep 13;35(1):142
pubmed: 27620004
Biomark Med. 2018 Mar;12(3):299-308
pubmed: 28841043
Oncol Rep. 2018 Aug;40(2):916-922
pubmed: 29845219
Oncol Rep. 2018 Jul;40(1):39-48
pubmed: 29749532
Int J Oncol. 2015 Feb;46(2):849-59
pubmed: 25420464
Cell Physiol Biochem. 2018;47(4):1533-1545
pubmed: 29940566
Hippokratia. 2010 Oct;14(4):236-40
pubmed: 21311629
Cell Death Differ. 2011 Nov;18(11):1702-10
pubmed: 21455217
Tumour Biol. 2016 Nov;37(11):15241-15252
pubmed: 27696291
Cell Mol Life Sci. 2022 Oct 29;79(11):572
pubmed: 36308630
Life Sci. 2019 Jan 15;217:271-282
pubmed: 30557546
PLoS One. 2015 Aug 11;10(8):e0133870
pubmed: 26263387
J Mol Neurosci. 2015 Jul;56(3):531-9
pubmed: 25603816
Methods Mol Biol. 2016;1402:271-286
pubmed: 26721498
Nature. 2005 Jun 9;435(7043):834-8
pubmed: 15944708
Oncol Lett. 2017 Sep;14(3):3760-3766
pubmed: 28927144
Nat Med. 2015 Sep;21(9):998-1009
pubmed: 26236991
Int J Biol Sci. 2013 Jun 28;9(6):587-97
pubmed: 23847441
Cell Physiol Biochem. 2017;42(3):999-1012
pubmed: 28683446
Expert Rev Mol Diagn. 2020 Nov;20(11):1121-1138
pubmed: 33103502
Int J Clin Exp Pathol. 2015 Oct 01;8(10):12853-60
pubmed: 26722476
Oncol Rep. 2018 Sep;40(3):1370-1378
pubmed: 29956811
Cell. 2009 Nov 25;139(5):871-90
pubmed: 19945376
Mol Cancer Res. 2008 May;6(5):735-42
pubmed: 18505919
Onco Targets Ther. 2018 Jan 18;11:427-440
pubmed: 29403287
Gene. 2018 Jul 30;665:141-148
pubmed: 29679755
Oncol Rep. 2019 Jun;41(6):3386-3392
pubmed: 31002365
Sci Rep. 2017 Jun 23;7(1):4194
pubmed: 28646148
Cell Death Dis. 2020 Mar 6;11(3):175
pubmed: 32144238
Acta Biochim Biophys Sin (Shanghai). 2018 Jan 1;50(1):91-97
pubmed: 29069287
Recent Pat Anticancer Drug Discov. 2017;12(2):128-135
pubmed: 28056753
Oncol Lett. 2018 Apr;15(4):4585-4591
pubmed: 29541229
Cancer Manag Res. 2020 Aug 21;12:7579-7587
pubmed: 32904410
Cytokine Growth Factor Rev. 2022 Oct;67:11-24
pubmed: 35934612
Oncol Res. 2018 Dec 27;27(1):99-106
pubmed: 29495975
J Med Biochem. 2016 Apr;35(2):137-143
pubmed: 28356873
Aging (Albany NY). 2019 Sep 22;11(18):7357-7385
pubmed: 31543507
Int J Biochem Cell Biol. 2018 Sep;102:59-70
pubmed: 29953965
Cancer Sci. 2011 Dec;102(12):2264-71
pubmed: 21883694
Int J Mol Med. 2018 Apr;41(4):1855-1866
pubmed: 29393355
Sci Rep. 2015 Aug 25;5:13350
pubmed: 26302825
Nat Rev Gastroenterol Hepatol. 2020 Feb;17(2):111-130
pubmed: 31900466
Asian Pac J Cancer Prev. 2015;16(10):4203-9
pubmed: 26028073
Oncotarget. 2016 Apr 26;7(17):24466-82
pubmed: 27016414
Cancer Biol Ther. 2020 Sep 1;21(9):769-781
pubmed: 32730165
J Exp Clin Cancer Res. 2014 Dec 31;33:113
pubmed: 25551793
J Cell Physiol. 2020 Nov;235(11):8461-8471
pubmed: 32324267
PLoS One. 2011;6(8):e23899
pubmed: 21909376
Biomolecules. 2022 Sep 21;12(10):
pubmed: 36291546
Apoptosis. 2018 Apr;23(3-4):237-250
pubmed: 29516317
Invest New Drugs. 2017 Apr;35(2):180-188
pubmed: 27917453
Biochem Biophys Res Commun. 2010 Sep 17;400(2):236-40
pubmed: 20727858
Oncotarget. 2017 May 30;8(22):36410-36422
pubmed: 28430582
Onco Targets Ther. 2019 Jan 25;12:849-859
pubmed: 30774372
Biochimie. 2018 Jan;144:21-27
pubmed: 29017924
Cytokine Growth Factor Rev. 2022 Jun;65:61-74
pubmed: 35597701
North Clin Istanb. 2019 Nov 22;7(1):81-86
pubmed: 32232211
Aging (Albany NY). 2020 Mar 25;12(7):5640-5650
pubmed: 32209726
In Vivo. 2018 Nov-Dec;32(6):1333-1337
pubmed: 30348685
Sci Rep. 2012;2:434
pubmed: 22666537
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Pharmacol Res. 2022 Feb;176:106041
pubmed: 34952200
Curr Drug Targets. 2010 Jun;11(6):745-51
pubmed: 20041844
Hum Pathol. 2019 Feb;84:133-141
pubmed: 30296520
Tumour Biol. 2013 Apr;34(2):963-71
pubmed: 23264087
FASEB J. 2019 Jan;33(1):264-274
pubmed: 29985646
Cell Signal. 2003 Nov;15(11):983-92
pubmed: 14499341
Gene. 2019 Mar 1;687:9-15
pubmed: 30415006
Cancer Gene Ther. 2018 Dec;25(11-12):300-308
pubmed: 30237418
Int J Mol Sci. 2021 Jan 31;22(3):
pubmed: 33572600
Gut. 2013 Sep;62(9):1315-26
pubmed: 22735571
BMC Gastroenterol. 2020 May 18;20(1):156
pubmed: 32423385
Clin Cancer Res. 2011 Apr 1;17(7):1722-30
pubmed: 21350001
Int J Cancer. 2015 Apr 1;136(7):1537-45
pubmed: 25159729
Cell Signal. 2016 Jun;28(6):688-98
pubmed: 26970186
Int J Oncol. 2013 Jan;42(1):219-28
pubmed: 23174819
World J Gastroenterol. 2014 Aug 14;20(30):10432-9
pubmed: 25132759
Arch Med Res. 2017 Jul;48(5):472-482
pubmed: 29133193
Eur J Cancer. 2011 Jan;47(2):163-74
pubmed: 21145728
Front Oncol. 2018 Jun 18;8:226
pubmed: 29967761
Oncol Rep. 2015 Apr;33(4):1828-36
pubmed: 25683168
Med Mol Morphol. 2017 Jun;50(2):76-85
pubmed: 27981410
Biochem Biophys Res Commun. 2017 Nov 25;493(3):1322-1328
pubmed: 28986250
Exp Ther Med. 2019 Jun;17(6):4363-4370
pubmed: 31086572
Exp Ther Med. 2016 Feb;11(2):625-630
pubmed: 26893657
Mol Cancer. 2018 Apr 24;17(1):84
pubmed: 29690888
Lancet Oncol. 2013 Dec;14(13):1295-306
pubmed: 24239208
Int J Cancer. 2008 Jul 15;123(2):372-379
pubmed: 18449891
Mol Ther Nucleic Acids. 2018 Sep 7;12:578-590
pubmed: 30195794
Gene. 2018 Dec 15;678:377-383
pubmed: 30118890
Cancer Cell Int. 2017 Apr 6;17:44
pubmed: 28396617

Auteurs

Nasim Ebrahimi (N)

Genetics Division, Department of Cell and Molecular Biology and Microbiology, Faculty of Science and Technology, University of Isfahan, Isfahan, Iran.

Ali Hakimzadeh (A)

Department of Medical Biotechnologies, University of Siena, Tuscany, Italy.

Farima Bozorgmand (F)

Department of Medical Nanotechnology, Faculty of Advanced Sciences and Technology, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran.

Sepehr Speed (S)

Medical Campus, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Mahdokht Sadat Manavi (MS)

Otolaryngology Department, Tehran University of Medical Science, Tehran, Iran.

Roya Khorram (R)

Bone and Joint Diseases Research Center, Department of Orthopedic Surgery, Shiraz University of Medical Sciences, Shiraz, Iran.

Kobra Farahani (K)

Department of Biology, Damghan Branch, Islamic Azad University, Damghan, Iran.

Fatemeh Rezaei-Tazangi (F)

Department of Anatomy, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.

Atena Mansouri (A)

Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Michael R Hamblin (MR)

Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, South Africa.
Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran.

Amir Reza Aref (AR)

Xsphera Biosciences, Translational Medicine group, Boston, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH